Uptake of oleoyl-chitosan nanoparticles by A549 cells

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 4, Issue 3, 2008, Pages 208-214

  Zhang, Jing ^a   Chen, Xi Guang ^a   Peng, Wei Bing ^a   Liu, Cheng Sheng ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

A549 cells; Cellular uptake; Fluorescein isothiocyanate (FITC); Nanoparticles

Indexed keywords

AMINES; CELL CULTURE; CELLS; CHEMOTHERAPY; CHITIN; CHITOSAN; CONCENTRATION (PROCESS); CYTOLOGY; DRUG DELIVERY; DRUG DOSAGE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GENE TRANSFER; GRAIN SIZE AND SHAPE; IMAGING TECHNIQUES; LIGHT EMISSION; LUMINESCENCE; MICROSCOPIC EXAMINATION; NANOPARTICLES; NANOSTRUCTURED MATERIALS; PARTICLE SIZE;

A549 CELLS; APPLICATIONS.; CELLULAR UPTAKE; CHITOSAN NANO-PARTICLES; DRUG CARRIERS; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE (FITC); GENE DELIVERY; HUMAN LUNGS; INCUBATION TIME; PARTICLE CONCENTRATIONS; SELF-ASSEMBLED;

NANOSTRUCTURES;

FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE; OLEOYL CHITOSAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENCAPSULATION; FLUORESCENCE MICROSCOPY; GENE TARGETING; HUMAN; HUMAN CELL; INCUBATION TIME; LUNG CARCINOMA; PARTICLE SIZE; SPECTROFLUOROMETRY;

CELL LINE, TRANSFORMED; CHITOSAN; DRUG CARRIERS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; NANOPARTICLES; OLEIC ACID; PARTICLE SIZE;

EID: 49649127608     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2008.03.006     Document Type: Article

References (33)

1. Oyewumi M.O., and Mumper R.J. Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles. Int J Pharm 251 (2003) 85-97
2. Jenning V., Gysler A., Schafer-Korting M., and Gohla S.H. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 49 (2000) 211-218
3. Coester C.J., Langer K., Briessen H.V., and Kreuter J. Gelatin nanoparticles by two step desolvation-a new preparation method, surface modifications and cell uptake. J Microencapsul 17 (2000) 187-193
4. Stella B., Arpicco S., Peracchia M.T., Desmaele D., Hoebeke J., Renoir M., et al. Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 89 (2000) 1452-1464
5. Gupta A.K., Gupta M., Yarwood S.J., and Curtis A.S.G. Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts. J Control Release 95 (2004) 197-207
6. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharm Rev 53 (2001) 283-318
7. Ramge P., Unger R.E., Oltrogge J.B., Zenker D., Begley D., Kreuter J., et al. Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells. Eur J Neurol 12 (2000) 1931-1940
8. Hashida M., Nishikawa M., and Takakura Y. Receptor-mediated cell specific delivery of drugs to the liver and kidney. In: Ogata N., Kim S.W., Feijen J., and Okano T. (Eds). Advanced biomaterials in biomedical engineering and drug delivery systems (1996), Springer-Verlag, Tokyo, Japan 86-90
9. Wattiaux R., Laurent N., Conninck S.W., and Jadot M. Endosomes, lysosomes: their implications in gene transfer. Adv Drug Deliv Rev 41 (2000) 201-208
10. Illum L., Jabbal-Gill I., Hinchcliffe M., Fisher A.N., and Davis S.S. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 51 (2001) 81-96
11. Janes K.A., Fresneau M.P., Marazuela A., Fabra A., and Alonso M.J. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 73 (2001) 255-267
12. Zhang J., Chen X.G., Li Y.Y., and Liu C.S. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomedicine 3 (2007) 258-265
13. Lamprecht A., and Benoit J.P. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release 112 (2006) 208-213
14. Khin Y.W., and Feng S.S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 (2005) 2713-2722
15. Florence A.T., Hillery A.M., Hussain N., and Jani P.U. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Control Release 36 (1995) 39-46
16. Zhang L.K., Hou S.X., Mao S.J., Wei D.P., Song X.G., and Lu Y. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells. Int J Pharm 287 (2004) 155-162
17. Huang M., Ma Z.S., Khor E., and Lim L.Y. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 19 (2002) 1488-1494
18. Delie F. Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv Drug Deliv Rev 34 (1998) 221-223
19. Suh K., Jeong B., Liu F., and Kim S.W. Cellular uptake study of biodegradable nanoparticles in muscular smooth cells. Pharm Res 12 (1998) 1495-1498
20. Li Y.Y., Chen X.G., Yu L.M., Wang S.X., Sun G.Z., and Zhou H.Y. Aggregation of hydrophobically modified chitosan in solution and at the air-water interface. J Appl Polym Sci 102 (2006) 1968-1973
21. Wan L., Hu F.Q., and Yuan H. Study of the uptake of chitosan oligosaccharide nanoparticles by A549 cells. Acta Pharm Sinica 39 (2004) 227-231
22. Chen X.G., Lee C.M., and Park H.J. O/W emulsification for the self-aggregation and nanoparticle formation of linoleic acid-modified chitosan in the aqueous system. J Agric Food Chem 51 (2003) 3135-3139
23. Rubinstein L.V., Shoemaker R.H., Paull K.D., Simon R.M., Tosini S., Skehan P., et al. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 82 (1990) 1113-1117
24. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82 (1990) 1107-1112
25. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., and Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur J Pharm Biopharm 50 (2000) 147-160
26. Schnitzer J.E. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev 49 (2001) 265-280
27. Li Y.Y., Chen X.G., Liu C.S., Cha D.S., Park H.J., and Lee C.M. Effect of the molecular mass and degree of substitution of oleoylchitosan on the structure, rheological properties, and formation of nanoparticles. J Agric Food Chem 55 (2007) 4842-4847
28. Suh H., Jeong B., Liu F., and Kim S.W. Cellular uptake study of biodegradable nanoparticles in vascular smooth muscle cells. Pharm Res 15 (1998) 1495-1498
29. Schipper N.G.M., Olsson S., Hoogstraate J.A., deBoer A.G., Vårum K.M., and Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm Res 14 (1997) 923-929
30. Desai M.P., Labhasetwar V., Walter E., Levy R.J., and Amidon G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 14 (1997) 1568-1573
31. Foster K.A., Yazdanian M., and Audus K.L. Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium. J Pharm Pharmacol 53 (2001) 57-66
32. Couvreur P., and Puisieux F. Nano- and microparticles for the delivery of polypeptides and proteins. Adv Drug Del Rev 10 (1993) 141-162
33. Jayanth P., Sanjeeb K., Swayam P., Tom B., and Vinod L. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles. Int J Pharm 262 (2003) 1-11